Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRNE
3151
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $410K | ﹤0.01% |
42,302
-167,596
| -80% | -$1.33M |
|
3152
PUT
General Mills
GIS
$19.3B
| $408K | ﹤0.01% |
6,700
| – | – |
|
|
SRDX
3153
DELISTED
Surmodics
SRDX
| $408K | ﹤0.01% |
7,518
-9,519
| -56% | -$522K |
|
3154
CALL
Shake Shack
SHAK
$2.67B
| $407K | ﹤0.01% |
3,800
| – | – |
|
3155
Alerus Financial
ALRS
$853M
| $406K | ﹤0.01% |
14,002
-10,161
| -42% | -$318K |
|
|
CHN
3156
DELISTED
China Fund
CHN
| $405K | ﹤0.01% |
13,285
+4,717
| +55% | +$140K |
|
3157
German American Bancorp
GABC
$1.92B
| $404K | ﹤0.01% |
10,860
-16,868
| -61% | -$707K |
|
3158
PUT
Signet Jewelers
SIG
$3.78B
| $404K | ﹤0.01% |
5,000
| – | – |
|
3159
CALL
Rio Tinto
RIO
$161B
| $403K | ﹤0.01% |
4,800
+100
| +2% | +$8.6K |
|
3160
Old Second Bancorp
OSBC
$1.31B
| $402K | ﹤0.01% |
32,328
+8,558
| +36% | +$115K |
|
|
SOHU
3161
Sohu.com
SOHU
$361M
| $401K | ﹤0.01% |
21,588
-10,636
| -33% | -$190K |
|
3162
National Healthcare
NHC
$3.25B
| $400K | ﹤0.01% |
5,733
-8,445
| -60% | -$614K |
|
3163
American Vanguard Corp
AVD
$71.2M
| $398K | ﹤0.01% |
22,729
-20,970
| -48% | -$398K |
|
3164
Ducommun
DCO
$2.89B
| $397K | ﹤0.01% |
7,270
-6,779
| -48% | -$385K |
|
3165
KVH Industries
KVHI
$181M
| $397K | ﹤0.01% |
32,343
-11,577
| -26% | -$157K |
|
3166
Myers Industries
MYE
$1.38B
| $397K | ﹤0.01% |
18,878
-25,829
| -58% | -$553K |
|
|
ARD
3167
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $397K | ﹤0.01% |
16,167
+11,778
| +268% | +$304K |
|
|
TKAT
3168
DELISTED
Takung Art Co., Ltd.
TKAT
| $396K | ﹤0.01% |
23,764
+22,764
| +2,276% | +$521K |
|
3169
CALL
Synchrony
SYF
$25.7B
| $393K | ﹤0.01% |
8,100
| – | – |
|
|
TVRD
3170
Tvardi Therapeutics
TVRD
$19M
| $393K | ﹤0.01% |
764
-345
| -31% | -$219K |
|
3171
WisdomTree US LargeCap Dividend Fund
DLN
$6.38B
| $392K | ﹤0.01% |
+6,512
| New | +$388K |
|
3172
Genmab
GMAB
$17.8B
| $392K | ﹤0.01% |
9,592
+9,339
| +3,691% | +$360K |
|
3173
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$638M
| $392K | ﹤0.01% |
+15,285
| New | +$386K |
|
3174
Insmed
INSM
$21.4B
| $392K | ﹤0.01% |
13,762
-138,015
| -91% | -$4.1M |
|
3175
PUT
Allstate
ALL
$67.6B
| $391K | ﹤0.01% |
3,000
| – | – |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.